Unique Opportunity to acquire a leading edge testing laboratory, DEA certified and ISO accredited. The majority of the testing performed is for exotic cannabinoids sourced from hemp, a rapidly growing market segment that is legal across the US. Compounds include CBD, THCp, CBN, and HHC; hemp/cannabis derived nutraceuticals. Seller was a first mover in recognizing the synergies of hemp testing in a DEA certified lab, that also performs CA state licensed cannabis testing. Seller recently added psychedelic mushroom testing with validated procedures for a full range of active compounds. Operating since 2008, this laboratory was built and is managed by its founder and seasoned long term employees. Seller uses a sophisticated and robust software system that has been customized to ensure comprehensive and efficient management of laboratory operations, data collection, SOPs and quality control. NDA and POF required.compounds.  Lease for 4,000 sq. ft at $6,500 per month NNN expires 6/30/27, up to $7,311.62.65 NNN in final year.  The lab is fully outfitted with top-line instrumentation that covers all required and prospective testing requirements. Agilent HPLC’s, Shimadzu GC MS/MS, and Perkin-Elmer ICP MS/MS are among the instruments, all purchased new. The lab’s technicians have been trained in maintenance and repair of the equipment, ensuring little interruption of operations.  400 Amps of power. Ample parking. In addition to its first mover advantage, Seller has budgeted generously for sales and marketing functions.  The internal sales force benefits from the reputation of Seller in the industry and is able to consistently grow sales.  Internet based techniques are also successfully employed, including direct email marketing and SEO.  Seller’s DEA certification, which takes more than a year to acquire, allows seller to provide any Federal and State hemp and cannabis testing while facing sparse competition. According to industry reports, the US CBD market was approximately $1.6 billion in 2021 and projected to expand at a compound annual growth rate (CAGR) exceeding 40% through 2030. The US hemp oil market, where testing requirements for THC are federally mandated, was 470 million in 2021 and is expected to expand at a CAGR of 18.5%. Seller is well positioned as new markets for hemp testing open up around the globe.  Psychedelic mushrooms are an exploding market for medical and recreational use; with regulations being crafted. Seller is amenable to seller financing for a portion of the purchase price.  NDA and POF required.